Screening and biomarker identification have improved prostate cancer outcomes, but prostate cancer progression remains a critical challenge. Mitochondria have garnered increasing attention in prostate and other cancers, and metabolic and non-metabolic mitochondrial contributions to cancer merit further investigation. In their study, Furnish and colleagues found that mitochondrial Rho GTPase 2 (MIRO2) expression is upregulated in recurrent and progressive prostate cancer, and that MIRO2 depletion via shRNA abrogates prostate cancer cell growth in vitro and in vivo. The authors identified MIRO2 protein interactors using MIRO2 immunoprecipitation and mass spectrometry and revealed general control nonderepressible (GCN1) is a MIRO2 binding partner. Mechanistically, the authors showed that MIRO2 facilitates GCN1-mediated activation of GCN2, which results in eukaryotic translation initiation factor 2 alpha (eIF2α) phosphorylation and transcriptional upregulation of transcriptional activator 4 (ATF4). Immunohistochemistry data from prostate cancer xenografts implicated HIF1α as an oncogenic MIRO2 regulator. Overall, this work presents a previously unknown...
Skip Nav Destination
Article navigation
1 April 2022
Highlights|
April 01 2022
Selected Articles from This Issue Available to Purchase
Online ISSN: 1557-3125
Print ISSN: 1541-7786
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
Mol Cancer Res (2022) 20 (4): 499.
Related Content
A commentary has been published:
MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress Signaling
A commentary has been published:
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
A commentary has been published:
Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer
Citation
Selected Articles from This Issue. Mol Cancer Res 1 April 2022; 20 (4): 499. https://doi.org/10.1158/1541-7786.MCR-20-4-HI
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Pay-Per-View 24-Hour Access
$50.00
Citing articles via
Advertisement